Table 1.
SARS-CoV antibodies utilized by this study
| Antibody | Reference | Protein specificity | Species | Class | Neutralization of SARS-CoV | Epitope |
|---|---|---|---|---|---|---|
| 240C | Tripp et al. (2005) | S | mouse | IgG2a | no | SA (490–510) |
| 341C | Tripp et al. (2005) | S | mouse | IgG2a | yes | SA (490–510) |
| 540C | Tripp et al. (2005) | S | mouse | IgG2a | yes | SA (490–510) |
| 154C | Tripp et al. (2005) | S | mouse | IgM | no | SB (270–350) |
| CR3022 | (ter Meulen et al., 2006) (GenBank: DQ168569 and DQ168570) | S | human | IgG1 | yes | SC (369–519) |
| NRC-772 | Made by BEI | S | rabbit | serum | yes | — |
| 472C | Tripp et al. (2005) | E | mouse | IgM | no | |
| 19C | Tripp et al. (2005) | M | mouse | IgM | no | |
| 283C | Tripp et al. (2005) | M | mouse | IgG1 | no | |
| 42C | Tripp et al. (2005) | N | mouse | IgM | no |